• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转译纳米治疗学重塑肺腺癌恶性胸腔积液中的免疫微环境。

Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.

机构信息

Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital, and Department of Chemistry, Jinan University, Guangzhou, 510632, China.

Department of Respiratory Disease, The State Key Laboratory of Respiratory Disease, China Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

出版信息

Adv Healthc Mater. 2021 Jun;10(12):e2100149. doi: 10.1002/adhm.202100149. Epub 2021 Apr 18.

DOI:10.1002/adhm.202100149
PMID:33870649
Abstract

Malignant pleural effusion (MPE) remains a treatment bottleneck in advanced lung cancer, due to its complicated microenvironments and "cold" immunity. Therefore, the search for therapeutic drugs to transform MPE to functionally "hot" one could advance the development of effective immunotherapeutic strategy. Herein, translational selenium nanoparticles coated with immune-modulating macromolecule lentinan (SeNPs@LNT) are designed to restore the dysfunctional immune cells in patient-derived MPE microenvironment. Internalization of the SeNPs@LNT can effectively reduce the immunosuppressive status by enhancing the proliferation of CD4 T cells and natural killer cells, and remodeling the tumor associated macrophages into tumoricidal M1 phenotype in MPE derived from patients presenting low Se levels in blood and pleural effusion. Th1, cytotoxic T cell, γδ T, and B cell functions are upregulated, and Th2, Th17, and Treg cells activity is downregulated. Furthermore, SeNPs@LNT can be gradually metabolized into SeCys2 to promote the production of metabolites associated with tumor growth inhibition and immune response activation in MPE microenvironment. In contrast, lung cancer markers and vitamin B6 metabolism are decreased. The translational SeNP-based nanotherapeutic strategy restores functional "cold" MPE to "hot" MPE to activate the immune responses of various immune cells in MPE of lung cancer patients.

摘要

恶性胸腔积液(MPE)仍然是晚期肺癌治疗的瓶颈,这是由于其复杂的微环境和“冷”免疫。因此,寻找治疗药物将 MPE 转化为功能上的“热”状态,可以推进有效的免疫治疗策略的发展。在此,设计了一种用免疫调节大分子香菇多糖(LNT)修饰的翻译硒纳米颗粒(SeNPs@LNT),以恢复患者来源的 MPE 微环境中功能失调的免疫细胞。SeNPs@LNT 的内化可以通过增强 CD4 T 细胞和自然杀伤细胞的增殖,将肿瘤相关巨噬细胞重塑为杀伤性 M1 表型,从而有效地减轻免疫抑制状态,而这些表型在血液和胸腔积液中硒水平较低的患者中产生。Th1、细胞毒性 T 细胞、γδ T 和 B 细胞功能上调,而 Th2、Th17 和 Treg 细胞活性下调。此外,SeNPs@LNT 可以逐渐代谢为 SeCys2,以促进与肿瘤生长抑制和免疫反应激活相关的代谢产物在 MPE 微环境中的产生。相比之下,肺癌标志物和维生素 B6 代谢减少。基于翻译硒纳米颗粒的纳米治疗策略将功能上的“冷”MPE 恢复为“热”MPE,以激活肺癌患者 MPE 中各种免疫细胞的免疫反应。

相似文献

1
Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.转译纳米治疗学重塑肺腺癌恶性胸腔积液中的免疫微环境。
Adv Healthc Mater. 2021 Jun;10(12):e2100149. doi: 10.1002/adhm.202100149. Epub 2021 Apr 18.
2
Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.巨噬细胞衍生的 CCL22 通过 IL-8 在恶性胸腔积液中促进免疫抑制性肿瘤微环境。
Cancer Lett. 2019 Jun 28;452:244-253. doi: 10.1016/j.canlet.2019.03.040. Epub 2019 Mar 27.
3
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.晚期肺癌恶性胸腔积液-巨噬细胞的 M1/M2 谱及可塑性。
Cancer Immunol Immunother. 2021 May;70(5):1435-1450. doi: 10.1007/s00262-020-02781-8. Epub 2020 Nov 11.
4
Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.胸腔内注射抗 PD1 抗体:恶性胸腔积液的一种新的治疗方法。
Front Immunol. 2021 Dec 13;12:760683. doi: 10.3389/fimmu.2021.760683. eCollection 2021.
5
CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion.CD39 鉴定出肺腺癌相关转移性胸腔积液中一种特定的 CD8+T 细胞群体。
BMC Immunol. 2023 Dec 12;24(1):53. doi: 10.1186/s12865-023-00590-z.
6
Th17/Treg imbalance in malignant pleural effusion.恶性胸腔积液中的Th17/Treg失衡
J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):27-32. doi: 10.1007/s11596-013-1066-2. Epub 2013 Feb 8.
7
TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T1/T17 Cell Response.TSAd 在 Myo9b 介导的恶性胸腔积液抑制中发挥重要作用,通过调节 T1/T17 细胞反应。
J Immunol. 2020 Nov 15;205(10):2926-2935. doi: 10.4049/jimmunol.2000307. Epub 2020 Oct 12.
8
Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.恶性胸腔积液中调节性T细胞/辅助性T细胞17失衡部分预示着预后不良。
Oncol Rep. 2015 Jan;33(1):478-84. doi: 10.3892/or.2014.3576. Epub 2014 Oct 30.
9
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.胸腔内纳米免疫疗法促进先天和适应性免疫反应,增强抗 PD-L1 治疗恶性胸腔积液。
Nat Nanotechnol. 2022 Feb;17(2):206-216. doi: 10.1038/s41565-021-01032-w. Epub 2021 Dec 16.
10
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.贝伐珠单抗联合化疗治疗恶性胸腔积液经引流或胸膜固定术控制不佳的非鳞状非小细胞肺癌患者:东北日本研究组试验 NEJ013B 的 II 期研究。
Thorac Cancer. 2020 Jul;11(7):1876-1884. doi: 10.1111/1759-7714.13472. Epub 2020 May 18.

引用本文的文献

1
Research progress of nano-based drug delivery systems based on stimuli-responsive materials for the treatment of lung diseases.基于刺激响应材料的纳米药物递送系统治疗肺部疾病的研究进展
Front Bioeng Biotechnol. 2025 Jul 31;13:1644007. doi: 10.3389/fbioe.2025.1644007. eCollection 2025.
2
Food-Derived Phytochemicals: Multicultural Approaches to Oxidative Stress and Immune Response.食物来源的植物化学物质:应对氧化应激和免疫反应的多元文化方法
Int J Mol Sci. 2025 Jul 29;26(15):7316. doi: 10.3390/ijms26157316.
3
Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy.
声动力疗法增强的仿生纳米平台将铁死亡和CD47作为癌症免疫治疗的薄弱环节进行靶向治疗。
J Nanobiotechnology. 2025 Jun 9;23(1):432. doi: 10.1186/s12951-025-03485-w.
4
Nanomaterials reshape the pulmonary mechanical microenvironment: novel therapeutic strategies for respiratory diseases.纳米材料重塑肺部力学微环境:呼吸系统疾病的新型治疗策略。
Front Bioeng Biotechnol. 2025 May 2;13:1597387. doi: 10.3389/fbioe.2025.1597387. eCollection 2025.
5
The role and mechanism of selenium in the prevention and progression of hepatocellular carcinoma.硒在肝细胞癌预防和进展中的作用及机制。
Front Oncol. 2025 Mar 20;15:1557233. doi: 10.3389/fonc.2025.1557233. eCollection 2025.
6
Selenium in cancer management: exploring the therapeutic potential.硒在癌症治疗中的应用:探索其治疗潜力。
Front Oncol. 2025 Jan 7;14:1490740. doi: 10.3389/fonc.2024.1490740. eCollection 2024.
7
Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application.用于共递送STAT3 siRNA脂质体和盐酸利多卡因的免疫治疗水凝胶,单次应用即可对非小细胞肺癌进行术后综合管理。
Asian J Pharm Sci. 2024 Jun;19(3):100925. doi: 10.1016/j.ajps.2024.100925. Epub 2024 May 3.
8
Translational selenium nanoparticles boost GPx1 activation to reverse HAdV-14 virus-induced oxidative damage.转化型硒纳米颗粒促进GPx1激活以逆转14型腺病毒诱导的氧化损伤。
Bioact Mater. 2024 May 7;38:276-291. doi: 10.1016/j.bioactmat.2024.04.034. eCollection 2024 Aug.
9
Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy.硒代氨基酸代谢重塑肿瘤微环境:从细胞毒性到免疫治疗。
Int J Biol Sci. 2024 May 5;20(7):2779-2789. doi: 10.7150/ijbs.95484. eCollection 2024.
10
Biosynthesis of fungus-based oral selenium microcarriers for radioprotection and immuno-homeostasis shaping against radiation-induced heart disease.基于真菌的口腔硒微载体的生物合成,用于辐射防护以及针对辐射诱发心脏病塑造免疫稳态。
Bioact Mater. 2024 Apr 23;37:393-406. doi: 10.1016/j.bioactmat.2024.03.034. eCollection 2024 Jul.